Illustrative image – not actual.Shantha Biotechnics may shift the location of its proposed Rs.60 crore Hyderabad multi product manufacturing facility to outside Andhra Pradesh, following the state government's decision not to buy Indian-made Hepatitis B vaccine for its free immunisation programme funded by the Bill Gates Foundation.
Earlier, the state government had called for bids for
the supply of the vaccine. Three companies including Shantha Biotechnics and
Bharat Biotech from Hyderabad, had responded to the tender. However, Bharat
Biotech got involved in a controversy when a police officer suffered
complication after being administered the company’s vaccine. This led the state
government to decide against using any Indian brands for its programme and
asked UNICEF to outsource the vaccine from external parties having World Health
Organisation (WHO) certification.
However, the managing director of Shantha Biotechnics,
Mr K I Varaprasada Reddy, claims that WHO certification is required only for
exporting the drug and not for its sale in India as the drug had already been
certified by the Drug Controller and endorsed by WHO.
